(VIANEWS) – HCI Group (HCI), Novo Nordisk A/S (NVO), Progyny (PGNY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. HCI Group (HCI)
26.6% sales growth and 18.24% return on equity
HCI Group, Inc., together with its subsidiaries, engages in the property and casualty insurance, reinsurance, real estate, and information technology businesses in Florida. It provides residential insurance products, such as homeowners, fire, flood, and wind-only insurance to homeowners, condominium owners, and tenants for properties, as well as offers reinsurance programs. The company also owns and operates waterfront properties and retail shopping centers, and an office building, as well as commercial properties for investment purposes. In addition, it designs and develops web-based applications and products for mobile devices, including SAMS, an online policy administration platform; Harmony, a policy administration platform; ClaimColony, an end-to-end claims management platform; and AtlasViewer, a mapping and data visualization platform. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Earnings Per Share
As for profitability, HCI Group has a trailing twelve months EPS of $4.18.
PE Ratio
HCI Group has a trailing twelve months price to earnings ratio of 20.55. Meaning, the purchaser of the share is investing $20.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.24%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 48%, now sitting on 504.83M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 2100% and 62%, respectively.
2. Novo Nordisk A/S (NVO)
23.6% sales growth and 88.77% return on equity
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Earnings Per Share
As for profitability, Novo Nordisk A/S has a trailing twelve months EPS of $2.42.
PE Ratio
Novo Nordisk A/S has a trailing twelve months price to earnings ratio of 39.58. Meaning, the purchaser of the share is investing $39.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 88.77%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Aug 17, 2023, the estimated forward annual dividend rate is 1.03 and the estimated forward annual dividend yield is 1.03%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Novo Nordisk A/S’s EBITDA is 2.11.
3. Progyny (PGNY)
20.9% sales growth and 12.06% return on equity
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Progyny has a trailing twelve months EPS of $0.51.
PE Ratio
Progyny has a trailing twelve months price to earnings ratio of 66.43. Meaning, the purchaser of the share is investing $66.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.06%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 36.8%, now sitting on 1.03B for the twelve trailing months.
Sales Growth
Progyny’s sales growth is 27.7% for the ongoing quarter and 20.9% for the next.
4. Medpace Holdings (MEDP)
17.8% sales growth and 66.57% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $8.53.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 32.35. Meaning, the purchaser of the share is investing $32.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 66.57%.
5. Alphabet (GOOGL)
12.3% sales growth and 25.33% return on equity
Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, hardware, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. It is also involved in the sale of apps and in-app purchases and digital content in the Google Play store; and Fitbit wearable devices, Google Nest home products, Pixel phones, and other devices, as well as in the provision of YouTube non-advertising services. The Google Cloud segment offers infrastructure, cybersecurity, data, analytics, AI, and machine learning, and other services; Google Workspace that include cloud-based collaboration tools for enterprises, such as Gmail, Docs, Drive, Calendar, and Meet; and other services for enterprise customers. The Other Bets segment sells health technology and internet services. The company was founded in 1998 and is headquartered in Mountain View, California.
Earnings Per Share
As for profitability, Alphabet has a trailing twelve months EPS of $5.22.
PE Ratio
Alphabet has a trailing twelve months price to earnings ratio of 25.34. Meaning, the purchaser of the share is investing $25.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.33%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11%, now sitting on 297.13B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Alphabet’s EBITDA is 5.41.
Previous days news about Alphabet(GOOGL)
- According to MarketWatch on Monday, 11 December, "The PHLX semiconductor index , Apple Inc. , Nvidia, Microsoft, Amazon.com Inc. , Alphabet Inc. and Tesla Corp. ."
- Alphabet (googl) adds generative AI features to notebooklm. According to Zacks on Monday, 11 December, "Moreover, growing generative AI capabilities position Alphabet well to compete with some industry leaders in the generative AI space, like Adobe (ADBE Quick QuoteADBE – Free Report) , which is gaining solid momentum on the back of its family of creative generative AI models, Firefly."
6. Tetra Technologies (TTI)
9.2% sales growth and 22.96% return on equity
TETRA Technologies, Inc., together with its subsidiaries, operates as an energy services and solutions company. It operates through two segments, Completion Fluids & Products Division and Water & Flowback Services. The Completion Fluids & Products segment manufactures and markets clear brine fluids, additives, and associated products and services to the oil and gas industry for use in well drilling, completion, and workover operations in the United States, as well as in Latin America, Europe, Asia, the Middle East, and Africa. This segment also markets liquid and dry calcium chloride products; and TETRA PureFlow ultra-pure zinc bromide to battery technology companies. The Water & Flowback Services segment provides water management services for onshore oil and gas operators. This segment also offers frac flowback, production well testing, and other associated services in oil and gas producing regions in the United States and Mexico, as well as in various basins in Latin America, Africa, Europe, and the Middle East. The company was incorporated in 1981 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, Tetra Technologies has a trailing twelve months EPS of $0.21.
PE Ratio
Tetra Technologies has a trailing twelve months price to earnings ratio of 21.55. Meaning, the purchaser of the share is investing $21.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.96%.
7. Assurant (AIZ)
8% sales growth and 12.3% return on equity
Assurant, Inc., together with its subsidiaries, provides lifestyle and housing solutions that support, protect, and connect consumer purchases in North America, Latin America, Europe, and the Asia Pacific. The company operates through three segments: Global Lifestyle, Global Housing, and Global Preneed. The Global Lifestyle segment provides mobile device protection products and services, and extended service contracts for consumer electronics and appliances, as well as assistance services; vehicle protection and related services; and credit and other insurance services. The Global Housing segment offers lender-placed homeowners insurance, manufactured housing, and flood insurance; and renters insurance and related products, as well as voluntary manufactured housing insurance, homeowners insurance, and other specialty products. The Global Preneed segment provides pre-funded funeral insurance, final need insurance, and related services. The company was formerly known as Fortis, Inc. and changed its name to Assurant, Inc. in February 2004. Assurant, Inc. was founded in 1892 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Assurant has a trailing twelve months EPS of $9.81.
PE Ratio
Assurant has a trailing twelve months price to earnings ratio of 17.13. Meaning, the purchaser of the share is investing $17.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.3%.
Moving Average
Assurant’s worth is above its 50-day moving average of $153.61 and way above its 200-day moving average of $134.39.
Sales Growth
Assurant’s sales growth is 5.7% for the current quarter and 8% for the next.
Volume
Today’s last reported volume for Assurant is 921081 which is 143.37% above its average volume of 378461.
